Fundraising Fox

Lung Therapeutics

Austin, US · Founded 2012 · Texas corporation · 2 known investors

lungtx.com ↗
Biotech

Founders & leadership

AF
Aaron FletcherDirector
JW
Joseph WoelkersDirector
SI
Steven IdellDirector
RM
Robert MillsDirector
JB
James Brian WindsorPresident and CEO

Investors · 2

UT Horizon FundAustin
Bios PartnersreportedFort Worthvia Aaron G.L. Fletcher · board

Reported raises · per SEC filings

Form D private placements
▶$10.1MraisedApr 2022 · 213 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles GarnerExecutive Officer
  • Aaron G.L. FletcherDirector
  • William C. FaireyDirector
  • Brian WindsorExecutive Officer, Director
Offering amount
$15M
Amount sold
$10.1M
Minimum investment
$15K
Finders' fees
$855.5K
Placement agents
Newbridge Securities Corporation
First sale
Mar 2022
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$38.7MraisedOct 2019 · 42 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven IdellDirector
  • Aaron FletcherDirector
  • R. A. SessionDirector
  • James Brian WindsorExecutive Officer, Director
  • Robert MillsDirector
Offering amount
$38.7M
Amount sold
$38.7M
First sale
May 2019
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$36.2MraisedMay 2019 · 38 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven IdellDirector
  • Aaron FletcherDirector
  • Robert MillsDirector
  • James Brian WindsorExecutive Officer, Director
  • R. A. SessionDirector
Amount sold
$36.2M
First sale
May 2019
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedJun 2018 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James Brian WindsorExecutive Officer, Director
  • Steven IdellDirector
  • Aaron FletcherDirector
  • Robert MillsDirector
  • Jim MervisDirector
Incorporated
Corporation, Texas
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedSep 2015 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Aaron FletcherDirector
  • Joseph WoelkersDirector
  • Steven IdellDirector
  • Robert MillsDirector
  • James Brian WindsorExecutive Officer, Director
Offering amount
$2.6M
Amount sold
$2.6M
First sale
Sep 2014
Incorporated
Corporation, Texas, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.